Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Director William C. Foote sold 2,736 shares of the business’s stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. Following the transaction, the director now owns 16,415 shares in the company, valued at approximately $1,105,878.55. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Shares of Walgreens Boots Alliance, Inc. (NASDAQ WBA) traded up $0.09 during trading hours on Friday, reaching $66.87. 14,070,000 shares of the company’s stock were exchanged, compared to its average volume of 8,640,000. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.07 and a quick ratio of 0.59. The company has a market capitalization of $67,510.00, a price-to-earnings ratio of 13.09, a PEG ratio of 1.19 and a beta of 1.20. Walgreens Boots Alliance, Inc. has a 12-month low of $63.82 and a 12-month high of $88.00.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.21 by $0.10. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The firm had revenue of $30.15 billion for the quarter, compared to the consensus estimate of $29.93 billion. During the same period in the prior year, the firm posted $1.07 earnings per share. The company’s revenue for the quarter was up 5.3% on a year-over-year basis. sell-side analysts expect that Walgreens Boots Alliance, Inc. will post 5.55 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Monday, November 13th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.39%. The ex-dividend date is Friday, November 10th. Walgreens Boots Alliance’s payout ratio is 42.33%.
Walgreens Boots Alliance announced that its Board of Directors has authorized a share repurchase plan on Wednesday, October 25th that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the pharmacy operator to repurchase shares of its stock through open market purchases. Shares repurchase plans are usually a sign that the company’s board of directors believes its stock is undervalued.
COPYRIGHT VIOLATION WARNING: “Walgreens Boots Alliance, Inc. (WBA) Director William C. Foote Sells 2,736 Shares” was originally posted by Community Financial News and is the property of of Community Financial News. If you are reading this article on another domain, it was illegally copied and republished in violation of United States and international copyright law. The legal version of this article can be accessed at https://www.com-unik.info/2017/11/04/walgreens-boots-alliance-inc-wba-director-william-c-foote-sells-2736-shares.html.
A number of institutional investors and hedge funds have recently made changes to their positions in WBA. Cedar Capital LLC purchased a new stake in Walgreens Boots Alliance in the first quarter valued at approximately $223,000. Teza Capital Management LLC purchased a new position in shares of Walgreens Boots Alliance during the first quarter worth approximately $1,663,000. HGK Asset Management Inc. raised its stake in shares of Walgreens Boots Alliance by 5.2% during the first quarter. HGK Asset Management Inc. now owns 8,065 shares of the pharmacy operator’s stock worth $670,000 after acquiring an additional 400 shares in the last quarter. Haverford Trust Co. raised its stake in shares of Walgreens Boots Alliance by 4.8% during the first quarter. Haverford Trust Co. now owns 8,957 shares of the pharmacy operator’s stock worth $744,000 after acquiring an additional 411 shares in the last quarter. Finally, Montecito Bank & Trust raised its stake in shares of Walgreens Boots Alliance by 3.9% during the first quarter. Montecito Bank & Trust now owns 6,431 shares of the pharmacy operator’s stock worth $534,000 after acquiring an additional 240 shares in the last quarter. 60.24% of the stock is currently owned by institutional investors and hedge funds.
A number of research analysts recently issued reports on the stock. Needham & Company LLC set a $94.00 target price on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Monday, July 17th. Loop Capital set a $90.00 target price on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Thursday, October 26th. Citigroup Inc dropped their target price on shares of Walgreens Boots Alliance from $95.00 to $81.00 and set a “buy” rating on the stock in a research report on Thursday. BidaskClub upgraded shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Wednesday, August 30th. Finally, Royal Bank Of Canada started coverage on shares of Walgreens Boots Alliance in a report on Tuesday, September 19th. They set an “outperform” rating and a $96.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and fourteen have assigned a buy rating to the company. Walgreens Boots Alliance has an average rating of “Buy” and an average price target of $87.63.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
What are top analysts saying about Walgreens Boots Alliance Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Walgreens Boots Alliance Inc. and related companies.